The standard initial treatment for testicular cancer involves surgically removing the affected testicle, a procedure aligned with current medical guidelines. Following surgery, the tumor undergoes thorough analysis to determine if further interventions are necessary.

According to a leading oncology professor, the success rate in treating testicular cancer has been remarkably high for over three decades, even in cases where the cancer has spread. Chemotherapy regimens, frequently enough combining cisplatin, etoposide, and bleomycin, boast healing rates exceeding 95 percent.

Personalized Therapy and Second Opinions

To minimize potential side effects, treatment plans should be highly individualized. Experts advise patients to seek a second opinion from specialists within a national network to ensure the most appropriate and effective therapy, mitigating the risk of overtreatment. It was noted that a third of patients with a testicular cancer tumor (a total of 1400 inquiries 2018) sought a second opinion last year.

“It is especially gratifying that testicular cancer has been healed very successfully for more than 35 years, even if metastases are already present.”

Sperm preservation Before Treatment

Chemotherapy,while effective,can significantly reduce sperm count. Urologists recommend that patients consider freezing their sperm before starting chemotherapy to preserve their fertility. This frozen sperm, known as cryosperma, can be stored for up to 30 years and used for future family planning.

Previously, patients bore the costs of sperm cryopreservation. However, since 2019, statutory health insurance companies now cover these costs, a change welcomed by experts like Mark Schrader.